The Rocky Mountain Neurology Translational Research Laboratory has been up and running for about two years now, with researchers from the Rocky Mountain MS Center at CU taking the lead…
Read More
Over the years, research has grown to become a cornerstone of the work of the Rocky Mountain MS Center at University of Colorado. As treatments have become more numerous and…
Instrumental in collaboration of international community of MS specialists in designing the first in-human trials for modern MS disease modifying therapies. Played key role with researchers across the world in…
Since 2008, Dr. Timothy Vollmer has not only been one of the primary neurologists seeing patients at the Rocky Mountain MS Center at University of Colorado, but has also served…
Researchers from the Rocky Mountain MS Center at University of Colorado and New York University are conducting a study to investigate the immune response to the COVID vaccine in multiple…
A Look at Current Research Priorities at the Rocky Mountain MS Center at University of Colorado The Rocky Mountain MS Center at University of Colorado is the home of one…
Quite a bit’s going on in the world of disease modifying therapies (DMTs), and we’ve prepared a brief update for you. Read on for more about Gilenya’s FDA approval for…
Over the last thirty years, we’ve refined our understanding of MS. With each research study, another dot is added to our picture of the disease. It’s certainly not a straight…
Earlier this fall, PCORI (the Patient Centered Outcomes Research Institute) released a request for funding applications for comparative effectiveness studies of Multiple sclerosis (MS) disease modifying therapies (DMTs). This includes…
https://youtu.be/79-neCtENZ8 Join the RMMSC’s Dr. Enrique Alvarez as he discusses the latest developments in MS research, including those presented at the 2016 ECTRIMS conference in Europe. If you were not…